Brief: Aclaris Therapeutics Announces Leadership Transition
28/07/2025 13:51
July 28 (Reuters) - Aclaris Therapeutics Inc ACRS.O: ACLARIS THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITION Source text: ID:nGNX5ZCqvD Further company coverage: ACRS.O (Reporting by Anshi Sancheti) ((Anshi.Sancheti@thomsonreuters.com;))
Recent news on Aclaris Therapeutics
See all newsAclaris Therapeutics Q1 net loss widens on higher R&D spending
Brief: Aclaris Therapeutics Q1 EPS USD -0.15 Vs. IBES Estimate USD -0.16
Brief: Aclaris Therapeutics Says Positive Full Top Line Results From Phase 1A Clinical Trial Of ATI-055
Brief: Aclaris Therapeutics Completes Enrollment In Phase 2 Trial Of Bosakitug (Ati-045) In Atopic Dermatitis
Aclaris Q4 loss narrows, but misses analysts' expectations